bf/NASDAQ:AXGN_icon.jpeg

NASDAQ:AXGN

Axogen

  • Stock

USD

Last Close

23.99

06/11 21:01

Market Cap

336.53M

Beta: 0.62

Volume Today

743.95K

Avg: 228.48K

PE Ratio

−18.28

PFCF: −17.18

    Description

    AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.25-0.2-0.15-0.1-0.052018-02-282020-02-242022-02-222023-11-072024-11-07

    Revenue (Estimate*)

    50M100M150M200M250M2018-02-282020-02-242022-02-222023-11-072024-11-07

    *Estimate based on analyst consensus